Triggers of treatment interruption and resumption among individuals with type 2 diabetes: a narrative cross-sectional qualitative study
- PMID: 40302273
- PMCID: PMC12044906
- DOI: 10.1080/17482631.2025.2496181
Triggers of treatment interruption and resumption among individuals with type 2 diabetes: a narrative cross-sectional qualitative study
Abstract
Purpose: Treatment interruption and resumption are common among people with type 2 diabetes mellitus (T2D), but the triggers of resumption, according to the reasons for interruption, remain underexplored. This study examined patterns of treatment interruption and resumption.
Methods: Narratives from 13 T2D patients with a history of treatment interruption were analysed through semi-structured interviews.
Results: Four patterns were identified: 1) "Economic rationality", where financial barriers caused interruptions, but resumption was facilitated by low-cost check-ups and updated patient mindsets to manage medical expenses within the constraints of a limited household budget; 2) "Proactive information seeking", where doubts about treatment effectiveness led to interruptions, followed by resumption through active health risk reassessment by the patient's self-directed efforts; 3) "Health professional-patient relationship", where conflicts with healthcare providers prompted interruptions, but trustful encounters encouraged resumption; and 4) "Sustained partnerships with community health professionals", where personal challenges caused interruptions, but non-coercive partnerships with community health professionals fostered resumption through strengthened patient commitment.
Conclusion: This study highlights the need for tailored medical support and local policy development for T2D patients, emphasizing subjective interpretations of their experiences on treatment interruption and resumption. Recognizing these patterns can guide resource allocation and the design of community-based diabetes care interventions.
Keywords: Treatment cessation; commitment; patient dropouts; public health nurse; secondary prevention; thematic analysis.
Conflict of interest statement
Mariko Inoue has been employed by and had a stock ownership of Novo Nordisk Pharma Ltd. Tomoo Hidaka, Rieko Suzuki, Katsue Hashimoto, Shota Endo, Takeyasu Kakamu, Mariko Gunji, Koichi Abe, and Tetsuhito Fukushima declare that they have no conflict of interest.
References
-
- Al-Qerem, W., Jarab, A., Eberhardt, J., Alasmari, F., Hammad, A., M Alkaee, S., & H Alsabaa, Z. (2024). Health literacy and medication adherence among patients with type 2 diabetes in Jordan: A cross-sectional study. Patient Preference and Adherence, 18, 2019–12. 10.2147/PPA.S484135 - DOI - PMC - PubMed
-
- Awotidebe, T. O., Adedoyin, R. A., Oke, K. I., Ativie, R. N., Opiyo, R., Ikujeyisi, E. O., Ikem, R. T., & Afolabi, M. A. (2017). Relationship between functional capacity and health-related quality of life of patients with type—2 diabetes. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 11(1), 1–5. 10.1016/j.dsx.2016.06.004 - DOI - PubMed
-
- Baca-Motes, K., Brown, A., Gneezy, A., Keenan, E. A., & Nelson, L. D. (2013). Commitment and behavior change: Evidence from the field. Journal of Consumer Research, 39(5), 1070–1084. 10.1086/667226 - DOI
-
- Basinger, E. D., Farris, M., & Delaney, A. L. (2019). Investigating the experience of diabetes stigma in online forums. The Southern Communication Journal, 85(1), 43–57. 10.1080/1041794X.2019.1655662 - DOI
-
- Boyatzis, R. E. (1998). Transforming qualitative information: Thematic analysis and code development. Sage.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical